Three-year Follow-Up of Neoadjuvant Chemotherapy with or Without Anthracyclines in the Presence of Dual HER2-blockade for HER2-positive Breast Cancer (TRAIN-2): A Randomized Phase III Trial.
JOURNAL OF CLINICAL ONCOLOGY(2020)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined